Loading clinical trials...
Loading clinical trials...
Clinical Research Platform on Treatment, Quality of Life and Outcome of Patients With Primary and Secondary Myelofibrosis and Anemia Who Are JAK Inhibitor Treatment-naïve or JAK Inhibitor Treatment-experienced (RHODOLITE)
Conditions
Locations
1
Germany
Multiple sites all over Germany
Multiple Locations, Germany
Start Date
February 19, 2026
Primary Completion Date
September 1, 2031
Completion Date
September 1, 2031
Last Updated
March 30, 2026
NCT07357727
NCT06343805
NCT06327100
NCT06361641
NCT04279847
NCT04455841
Lead Sponsor
iOMEDICO AG
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions